2021, Planning Resources, Scientific Sessions
  • Welcome to the 81st Scientific Sessions

    Welcome to the 81st Scientific Sessions

    “We have brought together the best and the brightest minds focused on diabetes research and diabetes care,” said ADA CEO Tracey D. Brown.


  • Weighing the costs vs. benefits of SGLT2 inhibitors and GLP-1 receptor agonists

    Weighing the costs vs. benefits of SGLT2 inhibitors and GLP-1 receptor agonists

    Hui Shao, MD, PhD, will discuss the financial implications these classes of agents, which have transformed diabetes care for individuals who also have cardiovascular disease, have brought to the health care system.


  • Experts will discuss the impact of social justice issues on vulnerable diabetes patient populations

    Experts will discuss the impact of social justice issues on vulnerable diabetes patient populations

    Shivani Agarwal, MD, MPH, Shakira Suglia, ScD, MS, and J. Frank Wharam, MD, MPH, will examine strategies to address risks influenced by social needs and to improve outcomes.


  • Debate to consider value of digital coaching for type 2 diabetes

    Debate to consider value of digital coaching for type 2 diabetes

    The digital diabetes care market will be worth upward of $700 million in 2022. Anne L. Peters, MD, and Kasia J. Lipska, MD, MHS, BS, will explore whether it is worth the cost.


  • Despite therapeutic advances, prevention and management of hypoglycemia still susceptible to ‘thinking traps’

    Despite therapeutic advances, prevention and management of hypoglycemia still susceptible to ‘thinking traps’

    Jennifer Sherr, MD, PhD, will highlight new glucagon formulations for treatment, and Nicole de Zoysa, DClinPsych, will review the impact of overcoming psychological obstacles on optimal hypoglycemia management.


  • Experts will examine emerging trends in pancreas transplantation

    Experts will examine emerging trends in pancreas transplantation

    The average ages of patients who are potentially eligible for pancreas transplantation and of potential organ donors are on the rise, but that is not the only challenge for this sector of the diabetes community, as Eelco J.P. de Koning, MD, PhD, will explain.


  • Presenter Perspectives: Professional Education and Development to Drive Integration—How Do We Teach and Beyond?

    Presenter Perspectives: Professional Education and Development to Drive Integration—How Do We Teach and Beyond?

    Jennifer LeBlanc, CDCES, shares details about this presentation, which begins Friday, June 25, at 12:00 p.m. ET.


  • Presenter Perspectives: Social Determinants of Metabolic Health—Evidence from Animal Models

    Presenter Perspectives: Social Determinants of Metabolic Health—Evidence from Animal Models

    Carol A. Shively, PhD, shares details about this presentation, which begins Friday, June 25, at 1:05 p.m. ET.


  • Presenter Perspectives: The State of Disparities in Pediatric Diabetes Care

    Presenter Perspectives: The State of Disparities in Pediatric Diabetes Care

    Ananta Addala, DO, MPH, shares details about this presentation, which begins Saturday, June 26, at 8:25 a.m. ET.


  • Presenter Perspectives: Cognitive Decline and Dementia in Diabetes

    Presenter Perspectives: Cognitive Decline and Dementia in Diabetes

    Florin Despa, PhD, shares details about this presentation, which begins Saturday, June 26, at 8:30 a.m. ET.